News
Policy & Recommendations
COP28: climate crisis is a health crisis, say scientific and health-focused organisations and experts
ESWI endorses a joint statement initiated by ERS and ELF to prioritise action to mitigate but also adapt to the health effects of climate change, to prepare societies and communities for a much more complex future.
PROGRAMMING survey on educational needs in the care of older people
The COST Action Promoting geriatric medicine in countries where it is still emerging (PROGRAMMING) has launched a survey aiming to map the educational interests and needs of current and future healthcare professionals in the field of care for older people
RSV IMMUNISATION FOR INFANTS IN EUROPE: ARE OUR HEALTH SYSTEMS READY?
EHMA publishes a paper based on expert insight from across Europe, exploring the challenges and opportunities of implementing RSV immunisation programmes in different country contexts.
|
9th Influenza Conference 2023
The Influenza B/Yamagata lineage appears to become extinct: implications for quadrivalent influenza vaccines?
SPI08 session from #ESWI2023
Guidance for Developing a Sustainable Multistakeholder Immunization Coalition
Insights from immunization coalition experts and analysis of successful immunization coalitions
Pandemic preparedness, response and recovery: Lessons learnt for global pharmacy
Investing in science and innovation is one of six key areas of development needed to prepare for future pandemics, according to a new report conducted by the International Pharmaceutical Federation (FIP).
WHO Europe and EPHA sign new MoU to strengthen collaboration for better health and well-being in Europe
The European Public Health Alliance have signed a memorandum of understanding with WHO Europe to enhance their partnership. Both organisations will work closely to address key health challenges and drive positive change.
|
ESWI Airborne: Burden of Disease
Burden of disease - A focus on acute respiratory viruses in older adults
Why should older adults be particularly careful of acute respiratory viruses? What are risk factors for adverse outcomes? Why is RSV typically under-diagnosed in adults compared with flu and what are some of the long-term impacts?